Aviceda Therapeutics
Cambridge, United States· Est.
Aviceda Therapeutics is a clinical-stage biotechnology company developing glyco-immunology based therapies for retinal diseases, including geographic atrophy.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $207.5M
About
Aviceda Therapeutics is a clinical-stage biotechnology company developing glyco-immunology based therapies for retinal diseases, including geographic atrophy.
OphthalmologyImmunology
Funding History
1Total raised:$207.5M
Venture$207.5M